Details
| Stereochemistry | UNKNOWN |
| Molecular Formula | C14H21NOS.ClH |
| Molecular Weight | 287.849 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CC[S+]([O-])CCCN1CCC2=C(C1)C=CC=C2
InChI
InChIKey=ATLSSFQKJXKSHB-UHFFFAOYSA-N
InChI=1S/C14H21NOS.ClH/c1-2-17(16)11-5-9-15-10-8-13-6-3-4-7-14(13)12-15;/h3-4,6-7H,2,5,8-12H2,1H3;1H
| Molecular Formula | C14H21NOS |
| Molecular Weight | 251.388 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | ClH |
| Molecular Weight | 36.461 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Originator
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/4698571
single oral doses of 100, 200, or 300 mg esproquine
Route of Administration:
Oral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:31:34 GMT 2025
by
admin
on
Mon Mar 31 18:31:34 GMT 2025
|
| Record UNII |
1P9E5C9137
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C29713
Created by
admin on Mon Mar 31 18:31:34 GMT 2025 , Edited by admin on Mon Mar 31 18:31:34 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
300000055471
Created by
admin on Mon Mar 31 18:31:34 GMT 2025 , Edited by admin on Mon Mar 31 18:31:34 GMT 2025
|
PRIMARY | |||
|
C002967
Created by
admin on Mon Mar 31 18:31:34 GMT 2025 , Edited by admin on Mon Mar 31 18:31:34 GMT 2025
|
PRIMARY | |||
|
23486-22-8
Created by
admin on Mon Mar 31 18:31:34 GMT 2025 , Edited by admin on Mon Mar 31 18:31:34 GMT 2025
|
PRIMARY | |||
|
31950
Created by
admin on Mon Mar 31 18:31:34 GMT 2025 , Edited by admin on Mon Mar 31 18:31:34 GMT 2025
|
PRIMARY | |||
|
1P9E5C9137
Created by
admin on Mon Mar 31 18:31:34 GMT 2025 , Edited by admin on Mon Mar 31 18:31:34 GMT 2025
|
PRIMARY | |||
|
CHEMBL2110833
Created by
admin on Mon Mar 31 18:31:34 GMT 2025 , Edited by admin on Mon Mar 31 18:31:34 GMT 2025
|
PRIMARY | |||
|
84974
Created by
admin on Mon Mar 31 18:31:34 GMT 2025 , Edited by admin on Mon Mar 31 18:31:34 GMT 2025
|
PRIMARY | |||
|
C72766
Created by
admin on Mon Mar 31 18:31:34 GMT 2025 , Edited by admin on Mon Mar 31 18:31:34 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ENANTIOMER -> RACEMATE | |||
|
|
PARENT -> SALT/SOLVATE | |||
|
|
ENANTIOMER -> RACEMATE |